Haemonetics Corporation
Ownership
Ownership Structure
Who owns Haemonetics Corporation (HAE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.7% of the shares are freely tradable; institutional investors hold 108.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 12.35 | 5,619,979 | -3.5 | 03/31/2026 |
| Neuberger Berman Group LLC | 7.83 | 3,560,918 | -7.9 | 03/31/2026 |
| AQR Capital Management LLC | 7.38 | 3,356,543 | +6.1 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.63 | 2,559,316 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.59 | 2,090,389 | +0.0 | 03/31/2026 |
| Ariel Investments, LLC | 4.53 | 2,060,966 | +0.0 | 06/30/2026 |
| State Street Corp | 3.90 | 1,772,898 | +2.5 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 3.48 | 1,585,222 | +19.5 | 06/30/2026 |
| Citadel Advisors Llc | 3.32 | 1,510,120 | +485.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.58 | 1,627,459 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Abernathy Robert E | Director | 27,519 | 2,961,044 $ | Jul 24, 2026 | direct |
| Kroll Mark W | Director | 27,295 | 2,936,942 $ | Jul 24, 2026 | direct |
| Zane Ellen M | Director | 21,911 | 2,357,624 $ | Jul 24, 2026 | direct |
| Pomeroy Claire | Director | 19,410 | 2,088,516 $ | Jul 24, 2026 | direct |
| Coyle Michael J | Director | 17,932 | 1,929,483 $ | Jul 24, 2026 | direct |
| Johnson Lloyd Emerson | Director | 15,471 | 1,664,680 $ | Jul 24, 2026 | direct |
| Bryant Diane M | Director | 9,664 | 1,039,846 $ | Jul 24, 2026 | direct |
| Madaus Martin D | Director | 2,538 | 273,089 $ | Jul 24, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 24, 2026 | Madaus Martin D | Director | Other | 2,538 | – | – |
| Jul 24, 2026 | Zane Ellen M | Director | Other | 2,538 | – | – |
| Jul 24, 2026 | Pomeroy Claire | Director | Other | 2,538 | – | – |
| Jul 24, 2026 | Kroll Mark W | Director | Other | 2,538 | – | – |
| Jul 24, 2026 | Johnson Lloyd Emerson | Director | Other | 2,538 | – | – |
| Jul 24, 2026 | Coyle Michael J | Director | Other | 2,538 | – | – |
| Jul 24, 2026 | Bryant Diane M | Director | Other | 2,538 | – | – |
| Jul 24, 2026 | Abernathy Robert E | Director | Other | 2,538 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.